APOD Knockout HEK293T Cell Line
Cat.No.:
EDC07812
Species:
Human
Cell Name:
HEK293T
Gene:
APOD
Gene ID:
347
Size:
1×10⁶cells
APOD Knockout HEK293T Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07812 |
|---|---|
| Product Name | APOD Knockout HEK293T Cell Line |
| Species | Human |
| Cell Line | HEK293T |
| Cellosaurus ID | CVCL_0063 |
| Cell Line Synonyms | Hek293T, HEK-293T, HEK 293T, HEK-293-T, HEK 293 T, 293-T, 293 T, 293T, Human Embryonic Kidney 293T, 293tsA1609neo |
| Gene ID | |
| Gene | APOD |
| Summary |
This gene encodes a component of high density lipoprotein that has no marked similarity to other apolipoprotein sequences. It has a high degree of homology to plasma retinol-binding protein and other members of the alpha 2 microglobulin protein superfamily of carrier proteins, also known as lipocalins. This glycoprotein is closely associated with the enzyme lecithin:cholesterol acyltransferase - an enzyme involved in lipoprotein metabolism. [provided by RefSeq, Aug 2008]
|
| Associated Diseases | Non-tumor |
| Digestion Time | 30 sec~1 min |
| Morphology | Adherent |
| Passage Ratio | 1:5 |
| Complete Culture Medium | DMEM+10% FBS+1% NEAA+1% GlutaMax |
| Freezing Medium | 95% complete culture medium + 5% DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HEK293T | STR Info (Cell bank) Cell Line: HEK293T | ||||
| Allele1 | Allele2 | Allele3 | Allele1 | Allele2 | Allele3 | |
| Amelogenin | X | X | ||||
| CSF1PO | 11 | 12 | 11 | 12 | ||
| D2S1338 | 19 | 19 | ||||
| D3S1358 | 15 | 16 | 17 | 15 | 16 | 17 |
| D5S818 | 8 | 9 | 8 | 9 | ||
| D7S820 | 11 | 11 | ||||
| D8S1179 | 11 | 12 | 14 | 12 | 14 | |
| D13S317 | 12 | 14 | 12 | 14 | ||
| D16S539 | 9 | 13 | 9 | 13 | ||
| D18S51 | 17 | 18 | 17 | 18 | ||
| D19S433 | 18 | 18 | ||||
| D21S11 | 28 | 30.2 | 28 | 30.2 | ||
| FGA | 23 | 23 | ||||
| Penta D | 9 | 10 | 9 | 10 | ||
| Penta E | 7 | 15 | 7 | 15 | ||
| TH01 | 7 | 9.3 | 7 | 9.3 | ||
| TPOX | 11 | 11 | ||||
| vWA | 16 | 19 | 16 | 19 | ||
| D6S1043 | 11 | |||||
| D12S391 | 19 | 21 | 19 | 21 | ||
| D2S441 | 11 | 15 | 11 | 15 | ||
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying APOD function, APOD Knockout HEK293T Cell Line or APOD overexpression HEK293T Cell Line?
The choice depends on whether you are studying APOD (apolipoprotein D)'s role as a lipocalin family secreted protein or modeling its functions in neurodegeneration and emerging biology. The Knockout line is the standard tool for asking whether APOD is required for these processes — APOD is an atypical apolipoprotein belonging to the lipocalin family (unlike other apolipoproteins which are amphipathic helix-rich); APOD has a typical lipocalin β-barrel that binds hydrophobic ligands (progesterone, pregnenolone, arachidonic acid, possibly oxidized lipids); APOD is highly expressed in nervous system and is a major component of breast cyst fluid. Overexpression is useful for studying APOD gain-of-function effects.
For APOD research, the EDITGENE APOD Knockout in HEK293T is a workhorse mechanistic platform. This product complements the parallel APOD Knockout in A-549 (also available) for cross-background validation. Rescue with wild-type APOD is the standard specificity control. The knockout is valuable for studying lipocalin family biology, neuroprotection mechanisms (APOD upregulation in aging and neurodegeneration), and emerging APOD-related biology.
What are the application scenarios for this model?
Primary applications:
• Lipocalin family biology: hydrophobic ligand (progesterone, arachidonic acid, oxidized lipids) binding analysis.
• Secreted lipocalin biology: conditioned media APOD analysis.
• Cross-background validation: parallel analysis with APOD KO in A-549 (also available).
• Discovery proteomics: APOD-binding partner identification in APOD-null versus rescued cells.
EDITGENE recommends this HEK293T-based model for systematic APOD biochemistry.
Is this APOD Knockout HEK293T Cell Line compatible with overexpression rescue experiments?
Yes. APOD rescue experiments require attention to secreted lipocalin architecture:
• Construct design: use a codon-modified APOD sequence with a small N-terminal tag (FLAG, HA, after signal peptide cleavage) or C-terminal tag carefully placed. APOD has signal peptide and mature lipocalin β-barrel domain — preserve protein integrity.
• Secretion validation: confirm conditioned media APOD secretion.
• Ligand-binding-deficient rescue: β-barrel cavity mutations disrupt hydrophobic ligand binding.
• Functional readout: rescue should restore APOD-dependent phenotypes identified during knockout characterization.
HEK293T transduces with very high efficiency and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download